AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36235739 — intervention group
Group type: COMPARATOR
Intervention: Control Group (no interventions)
Number of subjects: 1633
Study 36235739 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention Group (among participants whose parents’ educational attainment was above 9 years)
Number of subjects: 1633
Study 36235739 — intervention group
Group type: COMPARATOR
Intervention: Control Group (among participants whose parents’ educational attainment was above 9 years)
Number of subjects: 1633
Study 36235739 — intervention group
Group type: EXPERIMENTAL
Intervention: Level-Down (reduced SSB consumption)
Number of subjects: 1633
Study 33662054 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual cleaning
Number of subjects: 32
Study 33662054 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine-aided cleaning
Number of subjects: 32
Study 33662054 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of manual and machine-aided cleaning
Number of subjects: 32
Study 33662054 — intervention group
Group type: COMPARATOR
Intervention: No cleaning
Number of subjects: 32
Study 32444457 — intervention group
Group type: EXPERIMENTAL
Intervention: Linagliptin
Number of subjects: 6979
Study 32444457 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6979
Study 33933152 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 weeks of CMC1 joint distraction
Number of subjects: 52
Study 33933152 — intervention group
Group type: COMPARATOR
Intervention: 8 weeks of CMC1 joint distraction
Number of subjects: 52
Study 35102749 — intervention group
Group type: EXPERIMENTAL
Intervention: Belt electrode skeletal muscle electrical stimulation (B-SES) combined with conventional physical therapy for 20 minutes each
Number of subjects: 32
Study 35102749 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy for 20 minutes
Number of subjects: 32
Study 33888413 — intervention group
Group type: EXPERIMENTAL
Intervention: Fully automated multihormone artificial pancreas
Number of subjects: 9
Study 33888413 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified multihormone algorithm
Number of subjects: 9
Study 33888413 — intervention group
Group type: COMPARATOR
Intervention: Insulin‐alone artificial pancreas
Number of subjects: 9
Study 33888413 — intervention group
Group type: EXPERIMENTAL
Intervention: Final dual-hormone system (insulin and pramlintide)
Number of subjects: 9
Study 33888413 — intervention group
Group type: EXPERIMENTAL
Intervention: Multihormone arm
Number of subjects: 9
Study 33888413 — intervention group
Group type: COMPARATOR
Intervention: Insulin‐alone arm
Number of subjects: 9
Study 35837984 — intervention group
Group type: EXPERIMENTAL
Intervention: CamAPS FX closed loop system
Number of subjects: 98
Study 35837984 — intervention group
Group type: COMPARATOR
Intervention: Closed loop (CL) system
Number of subjects: 98
Study 35837984 — intervention group
Group type: COMPARATOR
Intervention: Insulin pump (with or without CGM)
Number of subjects: 98
Study 34344583 — intervention group
Group type: EXPERIMENTAL
Intervention: Ureteral access sheath (UAS) insertion (Group B)
Number of subjects: 181
Study 34344583 — intervention group
Group type: COMPARATOR
Intervention: No UAS insertion (Group A)
Number of subjects: 181
Study 34344583 — intervention group
Group type: EXPERIMENTAL
Intervention: UAS insertion (Group B)
Number of subjects: 181
Study 34344583 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall stone-free rate
Number of subjects: 181
Study 34344583 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinically insignificant residual fragments
Number of subjects: 181
Study 34344583 — intervention group
Group type: EXPERIMENTAL
Intervention: Final stone-free rate
Number of subjects: 181
Study 32135648 — intervention group
Group type: EXPERIMENTAL
Intervention: Chrono-chemotherapy combined with intensity modulated radiotherapy (IMRT)
Number of subjects: 160
Study 32135648 — intervention group
Group type: COMPARATOR
Intervention: Conventional chemotherapy combined with intensity modulated radiotherapy (IMRT)
Number of subjects: 160
Study 32135648 — intervention group
Group type: EXPERIMENTAL
Intervention: Chrono-chemotherapy combined with IMRT
Number of subjects: 160
Study 32135648 — intervention group
Group type: COMPARATOR
Intervention: Conventional chemotherapy combined with IMRT
Number of subjects: 160
Study 33815657 — intervention group
Group type: EXPERIMENTAL
Intervention: L-Arginine (5 grams per day)
Number of subjects: 17
Study 33815657 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 34082142 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh pomegranate juice (250 mL twice daily for 2 weeks)
Number of subjects: 26
Study 33143831 — intervention group
Group type: EXPERIMENTAL
Intervention: Sectra visualisation table (SVT)
Number of subjects: 50
Study 33143831 — intervention group
Group type: COMPARATOR
Intervention: Traditional lecture (TRAD)
Number of subjects: 50
Study 35192801 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual personal training (VIRT) using bodyweight resistance exercises for 3 weeks
Number of subjects: 20
Study 35192801 — intervention group
Group type: COMPARATOR
Intervention: Traditional supervised strength training (STUD) in a strength training studio for 3 weeks
Number of subjects: 20
Study 34831554 — intervention group
Group type: EXPERIMENTAL
Intervention: AET + ISP (40 g/day, 5 days a week for 8 weeks)
Number of subjects: 16
Study 34831554 — intervention group
Group type: COMPARATOR
Intervention: AET
Number of subjects: 16
Study 35656573 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery (LAP)
Number of subjects: 8410
Study 35656573 — intervention group
Group type: COMPARATOR
Intervention: Open surgery (OPEN)
Number of subjects: 8410
Study 34501299 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling
Number of subjects: 50
Study 34501299 — intervention group
Group type: COMPARATOR
Intervention: Control (no dry needling)
Number of subjects: 50
Study 32532339 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-Maasai adolescents
Number of subjects: 906
Study 32532339 — intervention group
Group type: EXPERIMENTAL
Intervention: Maasai adolescents
Number of subjects: 906
Study 32532339 — intervention group
Group type: COMPARATOR
Intervention: Adolescents from Longido district
Number of subjects: 906
Study 32532339 — intervention group
Group type: COMPARATOR
Intervention: Adolescents with good oral hygiene
Number of subjects: 906
Study 32532339 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-Maasai adolescents with DMFT > 0
Number of subjects: 906
Study 32532339 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-Maasai adolescents with 2Q/TMD > 0
Number of subjects: 906
Study 32532339 — intervention group
Group type: EXPERIMENTAL
Intervention: Maasai adolescents with DMFT > 0
Number of subjects: 906
Study 32532339 — intervention group
Group type: EXPERIMENTAL
Intervention: Maasai adolescents with 2Q/TMD > 0
Number of subjects: 906
Study 34523303 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg vaginal progesterone
Number of subjects: 100
Study 34523303 — intervention group
Group type: COMPARATOR
Intervention: 200 mg vaginal progesterone
Number of subjects: 100
Study 32013277 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine (0.5 mg/kg bolus followed by 0.12 mg/kg/h continuous infusion)
Number of subjects: 184
Study 32013277 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 184
Study 36481539 — intervention group
Group type: EXPERIMENTAL
Intervention: Hands-On Training Program (HTP)
Number of subjects: 167
Study 35266869 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet group (self-completing questionnaires via a dedicated website)
Number of subjects: 840
Study 35266869 — intervention group
Group type: COMPARATOR
Intervention: Telephone group (questionnaires administered during a telephone interview)
Number of subjects: 840
Study 35266869 — intervention group
Group type: COMPARATOR
Intervention: Matched sample from internet and telephone groups (1:1 ratio)
Number of subjects: 840
Study 32078929 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) for dissociative seizures
Number of subjects: 12
Study 32078929 — intervention group
Group type: COMPARATOR
Intervention: Standardized Medical Care (SMC)
Number of subjects: 12
Study 34949135 — intervention group
Group type: EXPERIMENTAL
Intervention: repetitive transorbital alternating current stimulation (rtACS)
Number of subjects: 16
Study 34949135 — intervention group
Group type: COMPARATOR
Intervention: sham treatment
Number of subjects: 16
Study 33685421 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1 monotherapy (80 mg/m2 orally administrated twice daily, at day 1–14, 16 cycles)
Number of subjects: 0
Study 33685421 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin with vinorelbine combination therapy (cisplatin 80 mg/m2 at day 1, vinorelbine 25 mg/m2 at day 1, 8, 4 cycles)
Number of subjects: 0
Study 32991728 — intervention group
Group type: EXPERIMENTAL
Intervention: Teams (inter-brain synchrony)
Number of subjects: 174
Study 32991728 — intervention group
Group type: EXPERIMENTAL
Intervention: Inter-brain synchrony
Number of subjects: 174
Study 32991728 — intervention group
Group type: COMPARATOR
Intervention: Self-reported group identification
Number of subjects: 174
Study 32014692 — intervention group
Group type: EXPERIMENTAL
Intervention: Full ACT website (12 sessions)
Number of subjects: 181
Study 32014692 — intervention group
Group type: EXPERIMENTAL
Intervention: Open components of ACT
Number of subjects: 181
Study 32014692 — intervention group
Group type: EXPERIMENTAL
Intervention: Engaged components of ACT
Number of subjects: 181
Study 32014692 — intervention group
Group type: COMPARATOR
Intervention: Waitlist
Number of subjects: 181
Study 32014692 — intervention group
Group type: EXPERIMENTAL
Intervention: Full ACT website
Number of subjects: 181
Study 35382963 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (2 mg/kg/h)
Number of subjects: 73
Study 35382963 — intervention group
Group type: COMPARATOR
Intervention: Ketamine (0.5 mg/kg/h)
Number of subjects: 73
Study 35382963 — intervention group
Group type: COMPARATOR
Intervention: Dexmedetomidine (0.5 mcg/kg/h)
Number of subjects: 73
Study 33509838 — intervention group
Group type: COMPARATOR
Intervention: SMS reminders (two SMS reminders sent 3 days and 1 day before the scheduled MCV1 date)
Number of subjects: 537
Study 33509838 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS reminders coupled with a KES 150 incentive (sent 3 days before the scheduled MCV1 date)
Number of subjects: 537
Study 33509838 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 537
Study 32544499 — intervention group
Group type: EXPERIMENTAL
Intervention: Root canals prepared with ProTaper Next X3 rotary instrument (Dentsply Sirona) in experimental groups 1 (2 independent canals) and 3 (3 independent canals)
Number of subjects: 40
Study 32544499 — intervention group
Group type: COMPARATOR
Intervention: Nonprepared roots with 2 independent canals in group 2
Number of subjects: 40
Study 32544499 — intervention group
Group type: COMPARATOR
Intervention: Nonprepared roots with 3 independent canals in group 4
Number of subjects: 40
Study 32544499 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of prepared roots with 2 canals (group 1) and nonprepared roots with 3 canals (group 4)
Number of subjects: 40
Study 32544499 — intervention group
Group type: EXPERIMENTAL
Intervention: Prepared roots with MM canal (group 3)
Number of subjects: 40
Study 34985236 — intervention group
Group type: EXPERIMENTAL
Intervention: End-range Maitland mobilization (MG)
Number of subjects: 40
Study 34985236 — intervention group
Group type: COMPARATOR
Intervention: Sham manual therapy technique (CG)
Number of subjects: 40
Study 34006049 — intervention group
Group type: COMPARATOR
Intervention: General Anesthesia (GA)
Number of subjects: 130
Study 34006049 — intervention group
Group type: EXPERIMENTAL
Intervention: Paravertebral Block (PVB) with GA
Number of subjects: 130
Study 32819981 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-messaging smartphone application with messages chosen by a reinforcement learning algorithm
Number of subjects: 276
Study 32819981 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-messaging smartphone application with uniform random messages from messaging banks
Number of subjects: 276
Study 32819981 — intervention group
Group type: COMPARATOR
Intervention: Weekly mood message (control group)
Number of subjects: 276
Study 34490850 — intervention group
Group type: EXPERIMENTAL
Intervention: ISC 17536 (28-day administration)
Number of subjects: 138
Study 34490850 — intervention group
Group type: COMPARATOR
Intervention: Placebo (28-day administration)
Number of subjects: 138
Study 32727149 — intervention group
Group type: EXPERIMENTAL
Intervention: Naftopidil
Number of subjects: 0
Study 32727149 — intervention group
Group type: EXPERIMENTAL
Intervention: Naftopidil analogues
Number of subjects: 0
Study 35668304 — intervention group
Group type: EXPERIMENTAL
Intervention: pembrolizumab plus chemotherapy
Number of subjects: 141
Study 35668304 — intervention group
Group type: COMPARATOR
Intervention: placebo plus chemotherapy
Number of subjects: 141
Study 34185279 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate diet (LCD)
Number of subjects: 45
Study 34185279 — intervention group
Group type: COMPARATOR
Intervention: Exercise (EX)
Number of subjects: 45
Study 35138182 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness intervention
Number of subjects: 284
Study 35138182 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful Eating intervention
Number of subjects: 284
Study 34415194 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild dysplasia (Dejour type A)
Number of subjects: 9
Study 34415194 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe dysplasia (Dejour type B)
Number of subjects: 9
Study 34415194 — intervention group
Group type: COMPARATOR
Intervention: Normal geometries
Number of subjects: 9
Study 32798834 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT Group (four-session, group-based ACT plus asthma education)
Number of subjects: 168
Study 32798834 — intervention group
Group type: COMPARATOR
Intervention: Control Group (group-based asthma education talk plus three telephone follow-ups)
Number of subjects: 168
Study 33079463 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g glycidyl ester-rich palm fat
Number of subjects: 12
Study 33079463 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 g 2/3-MCPD ester-rich hazelnut oil
Number of subjects: 12
Study 33079463 — intervention group
Group type: COMPARATOR
Intervention: Control exposure (background exposure)
Number of subjects: 12
Study 32465772 — intervention group
Group type: EXPERIMENTAL
Intervention: HeartMate 3 (HM3)
Number of subjects: 1020
Study 32465772 — intervention group
Group type: COMPARATOR
Intervention: HeartMate II (HMII)
Number of subjects: 1020
Study 36158840 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprostadil (40 μg, three times per day)
Number of subjects: 102
Study 36158840 — intervention group
Group type: COMPARATOR
Intervention: Isosorbide dinitrate (5 mg, three times per day)
Number of subjects: 102
Study 32971524 — intervention group
Group type: EXPERIMENTAL
Intervention: Silymarin (140 mg, 3 times a day)
Number of subjects: 82
Study 32971524 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 82
Study 32947299 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam sclerotherapy with 1:2 polidocanol to air ratio
Number of subjects: 30
Study 32947299 — intervention group
Group type: COMPARATOR
Intervention: Foam sclerotherapy with 1:4 polidocanol to air ratio
Number of subjects: 30
Study 34506937 — intervention group
Group type: EXPERIMENTAL
Intervention: Capsules containing 300 mg of standardized extract from B. forficata leaves (2% total flavonoid content)
Number of subjects: 92
Study 34506937 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 92
Study 33307353 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Remediation (CR)
Number of subjects: 984
Study 33307353 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 984
Study 33160882 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting high-intensity interval exercise (AME)
Number of subjects: 12
Study 33160882 — intervention group
Group type: COMPARATOR
Intervention: Postprandial high-intensity interval exercise (PME)
Number of subjects: 12
Study 32186030 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with usual care (AP + UC)
Number of subjects: 90
Study 32186030 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture combined with usual care (EA + UC)
Number of subjects: 90
Study 32186030 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 90
Study 35976497 — intervention group
Group type: EXPERIMENTAL
Intervention: In-office 6% HP paint-on varnish
Number of subjects: 3
Study 35976497 — intervention group
Group type: EXPERIMENTAL
Intervention: At-home 6% HP with adaptable tray
Number of subjects: 3
Study 35976497 — intervention group
Group type: EXPERIMENTAL
Intervention: At-home 16% carbamide peroxide with custom tray
Number of subjects: 3
Study 35976497 — intervention group
Group type: COMPARATOR
Intervention: All techniques (combined)
Number of subjects: 3
Study 33045271 — intervention group
Group type: EXPERIMENTAL
Intervention: 70% ethanol
Number of subjects: 80
Study 33045271 — intervention group
Group type: COMPARATOR
Intervention: 2.5% sodium hypochlorite
Number of subjects: 80
Study 33045271 — intervention group
Group type: COMPARATOR
Intervention: 17% EDTA‐T
Number of subjects: 80
Study 32333404 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple myeloma patients
Number of subjects: 283
Study 32333404 — intervention group
Group type: COMPARATOR
Intervention: Non-Hodgkin's lymphoma patients
Number of subjects: 283
Study 32333404 — intervention group
Group type: EXPERIMENTAL
Intervention: Plerixafor added to mobilization
Number of subjects: 283
Study 35420397 — intervention group
Group type: EXPERIMENTAL
Intervention: SARAsp‐Mix (biosimilar insulin aspart premix SAR341402 Mix 70/30)
Number of subjects: 402
Study 35420397 — intervention group
Group type: COMPARATOR
Intervention: NN‐Mix (originator insulin aspart mix 70/30 - NovoMix® 30)
Number of subjects: 402
Study 35420397 — intervention group
Group type: COMPARATOR
Intervention: SARAsp‐Mix vs NN‐Mix
Number of subjects: 402
Study 35420397 — intervention group
Group type: COMPARATOR
Intervention: SARAsp‐Mix and NN‐Mix
Number of subjects: 402
Study 34175862 — intervention group
Group type: EXPERIMENTAL
Intervention: Abrocitinib (200 mg)
Number of subjects: 942
Study 34175862 — intervention group
Group type: EXPERIMENTAL
Intervention: Abrocitinib (100 mg)
Number of subjects: 942
Study 34175862 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 942
Study 36401921 — intervention group
Group type: EXPERIMENTAL
Intervention: Parenteral vitamin C (100 mg/kg/d for 4 days)
Number of subjects: 40
Study 36401921 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 36401921 — intervention group
Group type: COMPARATOR
Intervention: Smokers
Number of subjects: 40
Study 36401921 — intervention group
Group type: COMPARATOR
Intervention: Nonsmoking controls
Number of subjects: 40
Study 36175097 — intervention group
Group type: EXPERIMENTAL
Intervention: Point-of-care nucleic acid amplification testing (POC-NAAT)
Number of subjects: 0
Study 36175097 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaled-up provider-initiated testing and counselling (SU-PITC)
Number of subjects: 0
Study 36175097 — intervention group
Group type: COMPARATOR
Intervention: Provider-initiated testing and counselling (PITC)
Number of subjects: 0
Study 36175097 — intervention group
Group type: COMPARATOR
Intervention: Comparison of POC-NAAT to PITC
Number of subjects: 0
Study 34672148 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate work rate increasing rate (30 W/min)
Number of subjects: 12
Study 34672148 — intervention group
Group type: COMPARATOR
Intervention: Relatively low work rate increasing rate (10 W/min)
Number of subjects: 12
Study 34672148 — intervention group
Group type: COMPARATOR
Intervention: Relatively high work rate increasing rate (60 W/min)
Number of subjects: 12
Study 34284321 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive strategy
Number of subjects: 0
Study 34284321 — intervention group
Group type: EXPERIMENTAL
Intervention: Restrictive strategy (30% of patients)
Number of subjects: 0
Study 34284321 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 34493575 — intervention group
Group type: EXPERIMENTAL
Intervention: Infarct progression rate (mL/h)
Number of subjects: 409
Study 34493575 — intervention group
Group type: EXPERIMENTAL
Intervention: Good outcome (modified Rankin Scale score 0-2)
Number of subjects: 409
Study 34493575 — intervention group
Group type: EXPERIMENTAL
Intervention: Collateral status
Number of subjects: 409
Study 34493575 — intervention group
Group type: EXPERIMENTAL
Intervention: Alberta Stroke Program Early CT Score (ASPECTS)
Number of subjects: 409
Study 34493575 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood glucose
Number of subjects: 409
Study 34493575 — intervention group
Group type: EXPERIMENTAL
Intervention: National Institutes of Health Stroke Scale (NIHSS) score
Number of subjects: 409
Study 32910084 — intervention group
Group type: EXPERIMENTAL
Intervention: Internal limiting membrane peeling (Group A)
Number of subjects: 258
Study 32910084 — intervention group
Group type: COMPARATOR
Intervention: No internal limiting membrane peeling (Group B)
Number of subjects: 258
Study 35883016 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranberry extract for symptoms of acute, uncomplicated UTI
Number of subjects: 26
Study 35883016 — intervention group
Group type: EXPERIMENTAL
Intervention: Script to explain the delayed antibiotic trial group
Number of subjects: 26
Study 35883016 — intervention group
Group type: EXPERIMENTAL
Intervention: Electronic diary for symptom rating
Number of subjects: 26
Study 34222630 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-caliber colonoscope
Number of subjects: 220
Study 34222630 — intervention group
Group type: COMPARATOR
Intervention: Standard colonoscope
Number of subjects: 220
Study 33066338 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic supplementation with Bifidobacterium breve PB04 and Lactobacillus rhamnosus KL53A
Number of subjects: 150
Study 33066338 — intervention group
Group type: COMPARATOR
Intervention: Control group (no probiotic supplementation)
Number of subjects: 150
Study 36243576 — intervention group
Group type: EXPERIMENTAL
Intervention: tranexamic acid 1 g
Number of subjects: 175
Study 36243576 — intervention group
Group type: EXPERIMENTAL
Intervention: tranexamic acid 0.5 g
Number of subjects: 175
Study 36243576 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 175